Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR Agonists as Vaccine Adjuvants Targeting Cancer and Infectious Diseases
Marina Luchner, Sören Reinke, Anita Milicic
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 142-142
Open Access | Times Cited: 212

Showing 1-25 of 212 citing articles:

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity
Tianhao Duan, Yang Du, Changsheng Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 491
Microbiome and cancer
Nyssa Cullin, Camila Azevedo Antunes, Ravid Straussman, et al.
Cancer Cell (2021) Vol. 39, Iss. 10, pp. 1317-1341
Open Access | Times Cited: 362
Vaccine adjuvants: mechanisms and platforms
Tingmei Zhao, Yulong Cai, Yujie Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 342
Recent advances in chemical protein synthesis: method developments and biological applications
Suwei Dong, Ji‐Shen Zheng, Yiming Li, et al.
Science China Chemistry (2024) Vol. 67, Iss. 4, pp. 1060-1096
Closed Access | Times Cited: 60
The promising role of tumor-associated macrophages in the treatment of cancer
Hongbin Wang, Xueying Wang, Xin Zhang, et al.
Drug Resistance Updates (2024) Vol. 73, pp. 101041-101041
Closed Access | Times Cited: 55
HMGB1 and Toll-like receptors: potential therapeutic targets in autoimmune diseases
Wenxuan Ren, Lei Zhao, Ying Sun, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 43
Babao Dan alleviates gut immune and microbiota disorders while impacting the TLR4/MyD88/NF-кB pathway to attenuate 5-Fluorouracil-induced intestinal injury
Bin Huang, Mengxuan Gui, Honglin An, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115387-115387
Open Access | Times Cited: 42
DNA Vaccines: Their Formulations, Engineering and Delivery
Michael Kozak, Jiafen Hu
Vaccines (2024) Vol. 12, Iss. 1, pp. 71-71
Open Access | Times Cited: 34
Cancer Nanovaccines: Nanomaterials and Clinical Perspectives
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 24
Unraveling the Complexities of Toll-like Receptors: From Molecular Mechanisms to Clinical Applications
Yi-Hsin Chen, Kang‐Hsi Wu, Han‐Ping Wu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5037-5037
Open Access | Times Cited: 19
Exploiting viral sensing mediated by Toll-like receptors to design innovative vaccines
Rossella Sartorius, Maria Trovato, Roberta Manco, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 94
Role of Inflammatory Mediators, Macrophages, and Neutrophils in Glioma Maintenance and Progression: Mechanistic Understanding and Potential Therapeutic Applications
Abdul Samad Basheer, Faridah Abas, Iekhsan Othman, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4226-4226
Open Access | Times Cited: 74
Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy
Lei Lei, Dennis Huang, Huile Gao, et al.
Science Advances (2022) Vol. 8, Iss. 47
Open Access | Times Cited: 64
Innate Immune Stimulation Using 3D Wireframe DNA Origami
Rebecca R. Du, Edward Cedrone, Anna Romanov, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20340-20352
Open Access | Times Cited: 51
Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
Jieun Han, Jaesung Lim, Chi‐Pin James Wang, et al.
Nano Convergence (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Advances of mRNA vaccine in tumor: a maze of opportunities and challenges
Yuan Yuan, Fan Gao, Ying Chang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 38
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 37
Four Ounces Can Move a Thousand Pounds: The Enormous Value of Nanomaterials in Tumor Immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 26
Open Access | Times Cited: 31
Adjuvants for COVID-19 Vaccines
Javier Castrodeza, Iván Sanz-Muñoz, José Marı́a Eiros Bouza
Vaccines (2023) Vol. 11, Iss. 5, pp. 902-902
Open Access | Times Cited: 30
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach
Somrita Padma, Ritwik Patra, Parth Sarthi Sen Gupta, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 525-525
Open Access | Times Cited: 27
Polymeric nanoparticle gel for intracellular mRNA delivery and immunological reprogramming of tumors
Sarah Y. Neshat, Chun Hei Ryan Chan, Jawaun J. Harris, et al.
Biomaterials (2023) Vol. 300, pp. 122185-122185
Open Access | Times Cited: 26
Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
Jie Liu, Tong Yang, Lei Dai, et al.
Bioactive Materials (2023) Vol. 31, pp. 315-332
Open Access | Times Cited: 25
Immunoinformatics-guided approach for designing a pan-proteome multi-epitope subunit vaccine against African swine fever virus
Alea Maurice Simbulan, Edward C. Banico, Ella Mae Joy S. Sira, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery
Suhair Sunoqrot, Sara A. Abdel Gaber, Razan Abujaber, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 8, pp. 4998-5019
Closed Access | Times Cited: 13
Tumor cell membrane‐based vaccines: A potential boost for cancer immunotherapy
Muyang Yang, Jie Zhou, Liseng Lu, et al.
Exploration (2024) Vol. 4, Iss. 6
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top